DK0552624T3 - Anvendelse af 9-cis-retinsyre, salte og estere deraf til behandling af epiteltumorer - Google Patents

Anvendelse af 9-cis-retinsyre, salte og estere deraf til behandling af epiteltumorer

Info

Publication number
DK0552624T3
DK0552624T3 DK93100257T DK93100257T DK0552624T3 DK 0552624 T3 DK0552624 T3 DK 0552624T3 DK 93100257 T DK93100257 T DK 93100257T DK 93100257 T DK93100257 T DK 93100257T DK 0552624 T3 DK0552624 T3 DK 0552624T3
Authority
DK
Denmark
Prior art keywords
esters
salts
treatment
retinoic acid
cis
Prior art date
Application number
DK93100257T
Other languages
Danish (da)
English (en)
Inventor
Werner Bollag
Joseph Francis Grippo
Arthur Levin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0552624T3 publication Critical patent/DK0552624T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
DK93100257T 1992-01-22 1993-01-11 Anvendelse af 9-cis-retinsyre, salte og estere deraf til behandling af epiteltumorer DK0552624T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82392892A 1992-01-22 1992-01-22
US82378692A 1992-01-22 1992-01-22
US82374192A 1992-01-22 1992-01-22
US82464792A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
DK0552624T3 true DK0552624T3 (da) 2000-09-25

Family

ID=27505866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93100257T DK0552624T3 (da) 1992-01-22 1993-01-11 Anvendelse af 9-cis-retinsyre, salte og estere deraf til behandling af epiteltumorer

Country Status (20)

Country Link
EP (1) EP0552624B1 (xx)
JP (1) JP3631259B2 (xx)
CN (2) CN1068200C (xx)
AT (1) ATE194077T1 (xx)
AU (1) AU667864B2 (xx)
CA (1) CA2087251C (xx)
CY (1) CY2251B1 (xx)
CZ (1) CZ282548B6 (xx)
DE (1) DE69328910T2 (xx)
DK (1) DK0552624T3 (xx)
ES (1) ES2148184T3 (xx)
GR (1) GR3034323T3 (xx)
HU (2) HU212734B (xx)
IL (1) IL104450A (xx)
NO (1) NO302274B1 (xx)
NZ (1) NZ245686A (xx)
PH (1) PH31621A (xx)
PT (1) PT552624E (xx)
RU (1) RU2119333C1 (xx)
TW (1) TW226329B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0617614T3 (da) 1991-12-18 1998-09-28 Salk Inst For Biological Studi Midler til modulering af processer medieret af retinoide receptorer og forbindelser anvendlige dertil
US7056954B2 (en) 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US5821254A (en) * 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
CA2218685A1 (en) * 1995-04-21 1996-10-24 Ligand Pharmaceuticals Incorporated Inhibition of apoptosis in cells expressing fas-ligand following activation
DE19523079A1 (de) * 1995-06-26 1997-01-02 Basf Ag Ester und Amide der 9(Z)-Retinsäure
JPH11511472A (ja) * 1995-09-18 1999-10-05 リガンド・ファーマシューティカルズ・インコーポレイテッド Ｒｘｒアゴニストを用いたｎｉｄｄｍの治療
US6028052A (en) * 1995-09-18 2000-02-22 Ligand Pharmaceuticals Incorporated Treating NIDDM with RXR agonists
TW442459B (en) * 1996-04-15 2001-06-23 Hoffmann La Roche Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
FR2765480B1 (fr) 1997-07-07 1999-09-10 Oreal Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
WO1999048529A1 (en) * 1998-03-20 1999-09-30 Warner-Lambert Company Retinoid-glitazone combinations
CA2369971A1 (en) 1999-04-07 2000-10-19 Sankyo Company, Limited Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
JP5249484B2 (ja) * 2001-12-11 2013-07-31 第一三共株式会社 医薬組成物
AU2003223477A1 (en) * 2002-04-05 2003-10-27 University Of Utah Research Foundation Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
AU2003270414A1 (en) * 2002-09-06 2004-03-29 Oregon Health And Science University Effect of vitamin a gel on paranasal sinus mucosal regeneration
EP1527774A1 (en) * 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
JP4825957B2 (ja) * 2005-03-29 2011-11-30 国立大学法人 鹿児島大学 抗腫瘍剤
KR101710505B1 (ko) 2009-09-15 2017-02-27 노벨리언 테라퓨틱스 인코포레이티드 리피드 비히클에 9-시스-레티닐 에스테르를 포함하는 약제 처방
SG184901A1 (en) * 2010-04-16 2012-11-29 Davos Life Science Pte Ltd Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
CN107308143A (zh) 2010-04-19 2017-11-03 诺维利昂治疗股份有限公司 用于治疗或改善与内源性类视黄醇缺乏有关的视觉障碍的治疗方案和方法
JP6576636B2 (ja) 2012-03-01 2019-09-18 ノベリオン セラピューティクス インコーポレイテッド 内因性レチノイド欠乏に関連する視覚障害における視覚機能を改善するための治療的計画および方法
JP6182728B2 (ja) * 2012-11-02 2017-08-23 国立大学法人名古屋大学 幹細胞を標的とした薬効及び毒性の評価法
WO2022051831A1 (pt) 2020-09-11 2022-03-17 Chemyunion Ltda. Composição, uso de composição, método cosmético e método para modular a produção de sebo
WO2023168608A1 (en) * 2022-03-08 2023-09-14 Mastery Biotech Co., Ltd. Pharmaceutical composition including retinoic acid and carbohydrate and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
ATE120090T1 (de) * 1987-04-06 1995-04-15 Daltex Medical Sciences Inc Behandlung gealterter haut mit oraler 13-cis- retinsäure.
US4994491A (en) * 1988-12-14 1991-02-19 Molecular Design International Dermal uses of trans-retinoids for the treatment of cancer
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute
DK0617614T3 (da) * 1991-12-18 1998-09-28 Salk Inst For Biological Studi Midler til modulering af processer medieret af retinoide receptorer og forbindelser anvendlige dertil

Also Published As

Publication number Publication date
CA2087251A1 (en) 1993-07-23
AU3186193A (en) 1993-07-29
JP3631259B2 (ja) 2005-03-23
HU212734B (en) 1996-10-28
NO930206L (no) 1993-07-23
CZ372892A3 (en) 1993-12-15
EP0552624A1 (en) 1993-07-28
PT552624E (pt) 2000-10-31
CN1155376C (zh) 2004-06-30
DE69328910T2 (de) 2001-01-11
CA2087251C (en) 2003-06-24
HUT63053A (en) 1993-07-28
NO302274B1 (no) 1998-02-16
NZ245686A (en) 1995-05-26
IL104450A (en) 1997-03-18
AU667864B2 (en) 1996-04-18
IL104450A0 (en) 1993-05-13
CN1256916A (zh) 2000-06-21
GR3034323T3 (en) 2000-12-29
DE69328910D1 (de) 2000-08-03
HU9300116D0 (en) 1993-04-28
PH31621A (en) 1999-01-12
RU2119333C1 (ru) 1998-09-27
NO930206D0 (no) 1993-01-21
CZ282548B6 (cs) 1997-08-13
CN1074826A (zh) 1993-08-04
TW226329B (xx) 1994-07-11
HU211167A9 (en) 1995-11-28
CN1068200C (zh) 2001-07-11
ATE194077T1 (de) 2000-07-15
EP0552624B1 (en) 2000-06-28
JPH06107542A (ja) 1994-04-19
CY2251B1 (en) 2003-07-04
ES2148184T3 (es) 2000-10-16

Similar Documents

Publication Publication Date Title
DK0552624T3 (da) Anvendelse af 9-cis-retinsyre, salte og estere deraf til behandling af epiteltumorer
RU93005355A (ru) Фармакологические композиции
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
DE3850109T2 (de) 13-trans-retinsäureester.
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
EP0213765A3 (en) A method and device for performing transluminal angioplasty
DE602004016847D1 (de) Topische verwendung von valproinsäure zur behandlung von psoriasis und akne
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
DE69315927T2 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
KR930016100A (ko) 약제학적 조성물
BG101126A (en) The use of muramylpeptide compounds
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
ES2054687T3 (es) Utilizacion de medetomidina en la fabricacion de un medicamento.
EP0274104A3 (de) 13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
ATE241359T1 (de) Topische und systemische anwendung von buspiron und seinen derivaten zur behandlung von pathologischen zuständen, die mit immunantworten verbunden sind
RU94016406A (ru) Способ лечения рожистого воспаления
IT8019033A0 (it) Metodo per il trattamento disuperfici siero-essudanti dell'epidermide, ferite, piaghe esimili, e mezzi per la sua attuazione.